Editorial Board
Editors-in-Chief
- Prof. Carlo M. Croce, PhD, Institute of Genetics, The Ohio State University, Columbus, Ohio, USA
- Prof. Kang Zhang, PhD, Center for Biomedicine and Innovations at Faculty of Medicine, Macau University of Science and Technology, China
- Prof. Yu-Quan Wei, PhD, National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, China
Associate Editors
- Rami I. Aqeilan, PhD, Milton Winograd Chair in Cancer Research, Lautenberg Center for Immunology and Cancer Research, Hebrew University of Jerusalem, Israel
- Ashley Bush, PhD, University of Melbourne, Australia
- Xuetao Cao, PhD, Chinese Academy of Medical Science, China
- Webster K. Cavenee, PhD, Ludwig Institute for Cancer Research University of California, San Diego, USA
- Xin-yuan Fu, PhD, National University of Singapore, Singapore
- Guangping Gao, PhD, Microbiology and Physiological Systems, University of Massachusetts Medical School, Massachusetts, USA
- Curtis Harris, PhD, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, USA
- Zhen Huang, PhD, Department of Chemistry & Department of Biology, Georgia State University, Atlanta, Georgia, USA
- Yibin Kang, PhD, Princeton University, USA
- Weimin Li, PhD, West China Hospital, Sichuan University, China
- Yang Liu, PhD, Center for Cancer and Immunology Research, Children's National Medical Center, Washington DC, USA
- Qing Richard Lu, PhD, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, USA
- Zhiyong Qian, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
- Dalla-Favera Riccardo, PhD, Cancer Center, Columbia University; Department of Pathology & Cell Biology, Columbia University, USA
- Hongbing Shu, PhD, Wuhan University, China,
- Shao-Cong Sun, PhD, University of Texas, MD Anderson Cancer Center, USA
- Koichi Tanaka, PhD, Kyoto University, Japan
- Philip N Tsichlis, PhD, The Ohio State University, USA
- Peter K. Vogt, PhD, The Scripps Research Institute, USA
- Rong Xiang, PhD, Nankai University, China
- Zhixiong Xiao, PhD, College of Life Sciences, Sichuan University, China
- Shengyong Yang, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Editorial Board Members
- Xiuwu Bian, PhD, Armed Forces Institute of Pathology, Network Center of Third Military Medical University, Chongqing, China
- Guojun Bu, PhD, Department of Neuroscience, Mayo Clinic, USA
- Shawn Burgess, PhD, National Human Genome Research Institute, National Institutes of Health, USA
- John C. Byrd, PhD, The Ohio State University, USA
- Lulu Cai, PhD, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China
- George A. Calin, PhD, MD Anderson Cancer Center, USA
- Yu Cao, PhD, West China Hospital, Sichuan University, China
- Thomas Carell, PhD, Ludwig-Maximilians-Universität München, Germany
- Chong Chen, PhD, West China Hospital, Sichuan University, China
- Guoqiang Chen, PhD, School of Medicine, Shanghai Jiao Tong University, China
- Zhijian Chen, PhD, UT Southwestern Medical Center,USA
- Eros Lazzerini Denchi, PhD, The Scripps Research Institute, La Jolla, USA
- Miguel Sena Esteves, PhD, University of Massachusetts Medical School, USA
- David Fruman, PhD, University of California, Irvine, USA
- Caiyun Fu, PhD, Zhejiang Sci-Tech University, China
- Xiangdong Fu, PhD, Univerisity of California, San Diego, USA
- Alan Garen, PhD, School of Medicine, Yale University, USA
- Mark Ginsberg, PhD, University of California, San Diego, USA
- JunLin Guan, PhD, Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, USA
- Junhong Han, PhD, West China Hospital, Sichuan University, China
- Stephen Hann, PhD, Vanderbilt University, Nashville, USA
- Ming-Liang He, PhD, City University of Hong Kong, China
- Nongyue He, PhD, School of Biological Science and Medical Engineering, Southeast University, China
- Matthew Vander Heiden, PhD, Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, USA
- Philip W. Hinds, PhD, Tufts University School of Medicine, USA
- Ying Hu, PhD, Harbin Institute of Technology, China
- Canhua Huang, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
- Wendong Huang, PhD, Department of Diabetes Complications and Metabolism, City of Hope National Medical Center, USA
- Shile Huang, PhD, Louisiana State University Health Sciences Center, USA
- Peter Illes, PhD, Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, University of Leipzig, Germany
- Lijun Jia, PhD, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, China
- JianSheng Kang, PhD, Zhengzhou University, China
- Tiebang Kang, PhD, Sun Yat-Sen University Cancer Center, China
- Kazunori Kataoka, PhD, The University of Tokyo, Japan
- Guido Kroemer, PhD, Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, France
- Peng Lei, PhD, West China Hospital, Sichuan University, China
- Qun-Ying Lei, PhD, Shanghai Medical College, Fudan University, China
- Bin Li, PhD, Jinan University, China
- Luyuan Li, PhD, State key laboratory of medicinal chemical biology, Nankai University, Tianjin, China
- Haitao Li, PhD, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China
- Lei Li, PhD, MD Anderson Cancer Center, USA
- Jinsong Li, PhD, Institute of Biochemistry and Cell Biology, Shanghai Institutes for biological Science, CAS, China
- Guomin Li, PhD, University of Texas Southwestern Medical Center, USA
- Wenbin Li, PhD, Beijing Tiantan Hospital, Capital Medical University, China
- Yongsheng Li, PhD, Chongqing University Cancer Hospital, China
- Shengcai Lin, PhD, School of Life Sciences, Xiamen University, China
- Shuo Lin, PhD, Department of Molecular, Cell & Developmental Biology, University of California, USA
- Feng Lin, PhD, Cleveland Clinic Lerner Research Institute, USA
- Lin Liu, PhD, College of Life Sciences, Nankai University, Tianjin, China
- Mofang Liu, PhD, Shanghai Institute of Biochemistry and Cell Biology, CAS, China
- Yu Liu, PhD, West China Hospital, Sichuan University, China
- Nathan Luedtke, PhD, University of Zurich, Switzerland
- Pralay Maiti, PhD, Indian Institute of Technology (Banaras Hindu University), India
- Guido Marcucci, PhD, City of Hope Comprehensive Cancer Center, USA
- Ruggero De Maria, PhD, Istituto Superiore di Sanita, Italy
- Ingo Mellinghoff, PhD, Memorial Sloan-Kettering Cancer Center, USA
- Hongming Miao, PhD, Army Medical University, China
- Karl Munger, PhD, Tufts University School of Medicine, USA
- Liang Ouyang, PhD, West China Hospital, Sichuan University, China
- Liqiang Pan, PhD, Zhejiang University, China
- Lianghu Qu, PhD, Sun Yat-sen University, China
- Athanasios G. Papavassiliou, PhD, Medical School, National and Kapodistrian University of Athens, Greece
- Zihe Rao, PhD, Tsinghua University, China
- Steve Rokita, PhD, Johns Hopkins University, USA
- Kanaga Sabapathy, PhD, Duke University, USA
- Alexey V. Semyanov, PhD, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia
- Hubing Shi, PhD, West China Hospital, Sichuan University, China
- Yanhong Shi, PhD, Beckman Research Institute of City of Hope,USA
- Erwei Song, PhD, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China
- Xiangrong Song, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
- Bing Su, PhD, Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, China
- Qiu Sun, PhD, West China Hospital, Sichuan University, China
- Ming Tan, PhD, China Medical University, Taiwan, China
- Yongguang Tao, PhD, Central South University, China
- David Tuveson, PhD, Cold Spring Habor Laboratory, USA
- Henning Ulrich, PhD, Institute of Chemistry, University of São Paulo, Brazil
- Alexei Verkhratsky, PhD, The University of Manchester, UK
- Francesco di Virgilio, PhD, University of Ferrara, Italy
- Daowen Wang, PhD, Huazhong University of Science and Technology, China
- Xiaofan Wang, PhD, Duke University, USA
- Yongsheng Wang, PhD, West China Hospital, Sichuan University
- Min Wu, PhD, Department of Basic Sciences, University of North Dakota, USA
- Hao Wu, PhD, Harverd Medical School and Boston Children's Hospital, USA
- Di Xia, PhD, National Institutes of Health, USA
- Xiao Xiao, PhD, Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, USA
- Tian Xu, PhD, Howard Hughes Medical Institute & Yale University School of Medicine, USA
- Xianjie Yang, PhD, UCLA School of Medicine, USA
- Pengyuan Yang, PhD, Institutes of Biomedical Sciences, Fudan University, China
- Dihua Yu, PhD, The University of Texas MD Anderson Cancer Center, USA
- Junying Yuan, PhD, Department of Cell Biology,Harvard Medical School, USA
- Qimin Zhan, PhD, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
- Zhiguo Zhang, PhD, Columbia University, USA
- Shimin Zhao, PhD, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai , China
- Pan Zheng, PhD, Children's National Medical Center, USA
- Weimin Zhong, PhD, Yale University, USA
- Chenchen Zhou, PhD, West China School of Stomatology, Sichuan University, China
- Qi Zhou, PhD, State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, China
- Weiguo Zhu, PhD, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Health Science Center, China